Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Paper
  • Published:

Antitumor effect and cellular immunity activation by murine interferon-β gene transfer against intracerebral glioma in mouse

Abstract

Cationic liposomes containing the human interferon-β (IFN-β) gene induce marked growth inhibition in human glioma cells. In vivo experiments using an human glioma implanted into the brains of nude mice have demonstrated a definite growth-inhibitory effect, achieving complete tumor regression with multiple intratumoral injections of the gene. However, nude mouse studies are inadequate to evaluate antitumor effects fully, especially those related to activation of the host immune response. This article aimed to investigate antitumor effects and immune response activation by murine IFN-β gene transfer in syngeneic mice. In vitro experiments demonstrated a stronger growth-inhibitory effect of liposomes containing the murine IFN-β gene on a GL261 mouse glioma cell line than exogenously added murine IFN-β. In in vivo experiments, intratumoral administration of liposomes containing the murine IFN-β gene resulted in a 16-fold reduction in the mean volume of residual gliomas in the brains of C57BL/6 mice and massive infiltration of cytotoxic T lymphocytes (CTL) within the residual tumor, while few CTL were infiltrated in controls including murine IFN-β, empty liposomes, naked plasmid expressing murine IFN-β, and liposomes containing β-galactosidase gene. In addition, 40% of mice treated with liposomes containing the murine IFN-β gene were completely cured. These findings indicated that activation of cellular immunity participates in antitumor effects in vivo together with direct effects of the IFN-β gene.

This is a preview of subscription content, access via your institution

Access options

Buy this article

Prices may be subject to local taxes which are calculated during checkout

Figure 1
Figure 2
Figure 3
Figure 4
Figure 5
Figure 6
Figure 7

Similar content being viewed by others

References

  1. Yoshida J, Kobayashi T, Kageyama N . Multimodality treatment of malignant glioma: effect of chemotherapy with ACNU and immunotherapy with N-CWS Neurol Med Chir 1984 24: 19–26

    Article  CAS  Google Scholar 

  2. Muller H, Brock M, Ernest H . Long-term survival and recurrence-free interval in combined surgical, radio- and chemotherapy of malignant brain gliomas Clin Neurol Neurosurg 1985 87: 167–171

    Article  CAS  PubMed  Google Scholar 

  3. Ram Z et al. Therapy of malignant brain tumors by intratumoral implantation of retroviral vector-producing cells Nature Med 1997 3: 1354–1361

    Article  CAS  PubMed  Google Scholar 

  4. Lundblad D, Lundgren E . Block of a glioma cell line in S by interferon Int J Cancer 1981 27: 749–754

    Article  CAS  PubMed  Google Scholar 

  5. Cook AW, Carter WA, Nidzgorski F, Akhtar L . Human brain tumor-derived cell lines: growth rate reduced by human fibroblast interferon Science 1983 219: 881–883

    Article  CAS  PubMed  Google Scholar 

  6. Yoshida J et al. Antitumor activity of interferon-β against malignant glioma in combination with chemotherapeutic agent of nitrosourea (ACNU) In: Cantell K, Schellekens H (eds) The Biology of the Interferon System Martinus Nijhoff: Boston 1986 pp 399–406

    Google Scholar 

  7. Yoshida J, Kajita Y, Wakabayashi T, Sugita K . Long-term follow-up results of 175 patients with malignant glioma: importance of radical tumour resection and postoperative adjuvant therapy with interferon, ACNU and radiation Acta Neurochir 1994 127: 55–59

    Article  CAS  PubMed  Google Scholar 

  8. Wells V, Mallucci L . Cell cycle regulation (G1) by autocrine interferon and dissociation between autocrine interferon and 2′, 5′-oligoadenylate synthetase expression J Interferon Res 1988 8: 793–802

    Article  CAS  PubMed  Google Scholar 

  9. Larsson I et al. Interferon production in glia and glioma cell lines Infect Immun 1978 22: 786–789

    CAS  PubMed  PubMed Central  Google Scholar 

  10. James D et al. Chromosome 9 deletion mapping reveals interferon α and interferon β-1 gene deletions in human glial tumors Cancer Res 1991 51: 1684–1688

    CAS  PubMed  Google Scholar 

  11. Mizuno M et al. Growth inhibition of glioma cells transfected with the human β-interferon gene by liposomes coupled with a monoclonal antibody Cancer Res 1990 50: 7826–7829

    CAS  PubMed  Google Scholar 

  12. Mizuno M, Yoshida J, Sugita K, Yagi K . Growth inhibition of glioma cells of different cell lines by human interferon-β produced in the cells transfected with its gene by means of liposomes J Clin Biochem Nutr 1990 9: 73–77

    Article  CAS  Google Scholar 

  13. Yagi K et al. Interferon-β endogenously produced by intratumoral injection of cationic liposome-encapsulated gene: cytocidal effect on glioma transplanted into nude mouse brain Biochem Mol Biol Int 1994 32: 167–171

    CAS  PubMed  Google Scholar 

  14. Yoshida J, Mizuno M, Yagi K . Antitumor effect of endogenous human β-interferon on malignant glioma and augmentation of the effect by tumor necrosis facter-α J Clin Biochem Nutr 1992 12: 153–160

    Article  CAS  Google Scholar 

  15. Yoshida J, Mizuno M, Yagi K . Secretion of human β-interferon into the cystic fluid of glioma transfected with the interferon gene J Clin Biochem Nutr 1991 11: 123–128

    Article  CAS  Google Scholar 

  16. Mizuno M, Yoshida J . Effect of human interferon-β gene transfer upon human glioma, transplanted into nude mouse brain, involves induced natural killer cells Cancer Immunol Immunother 1998 47: 227–232

    Article  CAS  PubMed  Google Scholar 

  17. Mori T et al. A consideration on pharmacokinetics of a new water-soluble anti-tumor nitrosourea, ACNU, in patients with malignant brain tumor Brain Nerve 1979 31: 601–606

    CAS  PubMed  Google Scholar 

  18. Takakura K et al. Effect of ACNU and radiotherapy on a malignant glioma J Neurosurg 1986 64: 53–57

    Article  CAS  PubMed  Google Scholar 

  19. Yoshida J, Mizuno M, Yagi K . Cytotoxity of human β-interferon produced in human glioma cells transfected with its gene by means of liposomes Biochem Int 1992 28: 1055–1061

    CAS  PubMed  Google Scholar 

  20. von Hoegen P . Synergistic role of type I interferons in the induction of protective cytotoxic T lymphocytes Immun Lett 1995 47: 157–162

    Article  CAS  Google Scholar 

  21. Chamberlain RS et al. Costimulation enhances the active immunotherapy effect of recombinant anticancer vaccines Cancer Res 1996 56: 2832–2836

    CAS  PubMed  PubMed Central  Google Scholar 

  22. Kuroki M et al. Antitumor effect of recombinant murine interferon-beta against mouse malignant glioma J Interferon Res 1987 7: 301–311

    Article  CAS  PubMed  Google Scholar 

  23. Watanabe Y, Kawade Y . Induction, production and purification of natural mouse IFN-α and -β In: Clemens MJ, Morris AG, Gearing AJH (eds) Lymphokines and Interferons: A Practical Approach IRL: Oxford 1987 pp 1–14

    Google Scholar 

Download references

Acknowledgements

We thank Mr Nobuaki Misawa and Ms Yoshie Ieda in the First Department of Pathology at the Nagoya University School of Medicine, Ms Miwako Nisizawa in the Department of Biochemistry at Aichi Cancer Center, and all participants in the Department of Clinical Pathology at the Kariya General Hospital for technical assistance.

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Natsume, A., Mizuno, M., Ryuke, Y. et al. Antitumor effect and cellular immunity activation by murine interferon-β gene transfer against intracerebral glioma in mouse. Gene Ther 6, 1626–1633 (1999). https://doi.org/10.1038/sj.gt.3300990

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/sj.gt.3300990

Keywords

This article is cited by

Search

Quick links